Lactobacillus salivarius is a well-known lactic acid bacterium to which increasing attention has been paid recently for use as probiotics for humans and animals. L. salivarius NIAS840 was first isolated from broiler chicken feces, displaying antimicrobial activities against multidrug-resistant Staphylococcus aureus and Salmonella enterica serovar Typhimurium. Here, we report the genome sequence of L. salivarius NIAS840 (2,046,557 bp) including a small plasmid and two megaplasmids.
The genus Lactobacillus is a member of the lactic acid bacteria and includes a diverse group of bacteria currently comprising 174 validly named species (http://www.bacterio.cict.fr/). Lactobacilli have been studied extensively due to their importance for the production of fermented foods (8) , and more recently, some of them have also been used as probiotics (6) . Lactobacillus salivarius has been usually found in the indigenous microbiota of the gastrointestinal tract of humans and animals, and its genomic diversity has been well reviewed recently (7) . The genome architecture of L. salivarius was first revealed from strain UCC118, whose genome consisted of a 1.83-Mb chromosome, a 242-kb megaplasmid, and two smaller plasmids (2) . A complete genome sequence of L. salivarius CECT 5713, which was isolated from human milk and infant feces, has also been reported recently to consist of a genome architecture similar to that of strain UCC118 (4).
L. salivarius NIAS840 was first isolated from broiler chicken feces, displaying antimicrobial activities against multidrugresistant Staphylococcus aureus and Salmonella enterica serovar Typhimurium. To unravel the genomic properties of strain NIAS840, we carried out whole-genome sequencing. Here, we report the genome sequence of strain NIAS840 (2,046,557 bp). The genome was sequenced by a whole-genome shotgun strategy using a combination of Roche 454 GS FLX Titanium pyrosequencing (454 Life Sciences, Branford, CT) and Solexa technology (Illumina, San Diego, CA). The initial sequence reads generated by pyrosequencing were assembled by the Newbler GS assembler 2.3 (454 Life Sciences). The resulting 113 contigs were then ordered into large scaffolds by using CLC Genomics Workbench 4 (CLC Bio, Cambridge, MA).
The annotation of open reading frames (ORFs) and noncoding RNAs was done by using the RAST (Rapid Annotation using Subsystem Technology) server and checked by BLAST analysis when needed.
The genome of L. salivarius NIAS840 consists of a circular chromosome of 1,705,688 bp, two megaplasmids (pNA1, 180,095 bp, and pNA2, 143,892 bp), and a smaller plasmid (pNA3, 16,882 bp). This genome architecture was distinguished from those of other Lactobacillus salivarius strains whose genomes were reported to contain only one megaplasmid (2, 4, 5) . The DNA GϩC content of the chromosome is 33.0% and similar to those of two megaplasmids and a plasmid. The entire genome of L. salivarius NIAS840 contains 1,917 protein-coding genes, 24 rRNA-coding genes, and 81 tRNAcoding genes. Several genes related to exopolysaccharide (EPS) biosynthesis were found in the chromosome, and the genes encoding mucus-and fibronectin/fibrinogen-binding proteins known to participate in cell adhesion were also found (1). The sequence of the megaplasmid pNA2 revealed the presence of a gene encoding choloylglycine hydrolase, implicating the bile acid tolerance of this strain (3) . Unlike the genomes of strain UCC118 and strain CECT 5713, the genes related to bacteriocin activity were not present. The presence of several genes encoding an ABC-type antimicrobial peptide transport system and multidrug resistance efflux pump also suggests its potential for probiotic use.
Nucleotide sequence accession number. Genome information for the chromosome and the plasmids of L. salivarius NIAS840 has been deposited in the GenBank database under accession no. AFMN00000000. 
